These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 3807827)
1. Dietary calcium deprivation and secondary hyperparathyroidism in patients treated with chronic dialysis. Popovtzer MM; Michael UF; Johnson-Dial KS; Ronstadt C; Nelson D; Ogden DA Miner Electrolyte Metab; 1986; 12(5-6):298-302. PubMed ID: 3807827 [TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
3. Secondary hyperparathyroidism in patients on maintenance hemodialysis. Hida M Tokai J Exp Clin Med; 1982 Nov; 7(6):665-70. PubMed ID: 7184198 [TBL] [Abstract][Full Text] [Related]
4. The interaction of PTH and dietary phosphorus and calcium on serum calcitriol levels in the rat with experimental renal failure. Martin-Malo A; Rodriguez M; Martinez ME; Torres A; Felsenfeld AJ Nephrol Dial Transplant; 1996 Aug; 11(8):1553-8. PubMed ID: 8856210 [TBL] [Abstract][Full Text] [Related]
5. Lack of correlation between calcium intake and serum calcium levels in stable haemodialysis subjects. Byrne FN; Kinsella S; Murnaghan DJ; Kiely M; Eustace JA Nephron Clin Pract; 2009; 113(3):c162-8. PubMed ID: 19672114 [TBL] [Abstract][Full Text] [Related]
6. [Prevalence of secondary hyperparathyroidism (SHPT) and causal factors in adult population in Reykjavík area]. Karlsson SL; Indridason OS; Franzson L; Sigurdsson G Laeknabladid; 2005 Feb; 91(2):161-9. PubMed ID: 16155312 [TBL] [Abstract][Full Text] [Related]
7. [Early treatment of secondary hyperparathyroidism in moderate renal insufficiency: low-phosphorus diet versus calcium carbonate]. Aresté N; Amor J; Cambil T; Salgueira M; Sánchez-Palencia R; Páez C; Gómez O; Palma A Nefrologia; 2003; 23 Suppl 2():64-8. PubMed ID: 12778857 [TBL] [Abstract][Full Text] [Related]
8. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients. Mazzaferro S; Pasquali M; Farcomeni A; Vestri AR; Filippini A; Romani AM; Barresi G; Pugliese F Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320 [TBL] [Abstract][Full Text] [Related]
9. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis. Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251 [TBL] [Abstract][Full Text] [Related]
10. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis. Nasri H; Baradaran A; Naderi AS Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479 [TBL] [Abstract][Full Text] [Related]
11. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis. Nasri H; Baradaran A J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608 [TBL] [Abstract][Full Text] [Related]
12. [Low dosage intravenous calcitriol bolus therapy in chronic hemodialysis patients]. Neyer U; Wöss E; Drexel H Acta Med Austriaca; 1994; 21(5):129-32. PubMed ID: 7709710 [TBL] [Abstract][Full Text] [Related]
13. RenaGel efficacy in severe secondary hyperparathyroidism. Castro R; Herman A; Ferreira C; Travassos F; Nunes-Azevedo J; Oliveira M Nefrologia; 2002; 22(5):448-55. PubMed ID: 12497746 [TBL] [Abstract][Full Text] [Related]
14. Oral calcium effectively reduces parathyroid hormone levels in hemodialysis patients: a randomized double-blind placebo-controlled study. Rudnicki M; Højsted J; Petersen LJ; Sørensen HA; Hyldstrup L; Transbøl I Nephron; 1993; 65(3):369-74. PubMed ID: 8289986 [TBL] [Abstract][Full Text] [Related]